(S)-Indoximod (1-Methyl-L-tryptophan) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with potential applications in cancer therapy; it exhibits synergistic effects when combined with clinically used chemotherapeutic agents such as cyclophosphamide, cisplatin, doxorubicin, or paclitaxel, making it a promising candidate for chemo-immunotherapy; it also demonstrates anti-hepatotoxic and immunostimulatory activities; traditionally, abrine (a related compound from Abrus precatorius seeds) is used externally for treating scabies, tinea, and boils due to its anti-inflammatory, insecticidal, and anti-swelling properties, but it is toxic and not for internal use.